Star Equity (STRR) Competitors $2.19 +0.03 (+1.20%) Closing price 03:50 PM EasternExtended Trading$2.14 -0.05 (-2.10%) As of 04:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock STRR vs. NXL, NEPH, RVP, NXGL, QTI, PTHL, IRIX, XAIR, LFWD, and VVOSShould you be buying Star Equity stock or one of its competitors? The main competitors of Star Equity include Nexalin Technology (NXL), Nephros (NEPH), Retractable Technologies (RVP), NEXGEL (NXGL), QT Imaging (QTI), Pheton Holdings Ltd Class A Ordinary Shares (PTHL), IRIDEX (IRIX), Beyond Air (XAIR), ReWalk Robotics (LFWD), and Vivos Therapeutics (VVOS). These companies are all part of the "medical equipment" industry. Star Equity vs. Nexalin Technology Nephros Retractable Technologies NEXGEL QT Imaging Pheton Holdings Ltd Class A Ordinary Shares IRIDEX Beyond Air ReWalk Robotics Vivos Therapeutics Star Equity (NASDAQ:STRR) and Nexalin Technology (NASDAQ:NXL) are both small-cap multi-sector conglomerates companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment, community ranking and earnings. Do analysts recommend STRR or NXL? Nexalin Technology has a consensus target price of $5.00, suggesting a potential upside of 179.33%. Given Nexalin Technology's stronger consensus rating and higher probable upside, analysts plainly believe Nexalin Technology is more favorable than Star Equity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Star Equity 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Nexalin Technology 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, STRR or NXL? Star Equity has a beta of 0.67, indicating that its share price is 33% less volatile than the S&P 500. Comparatively, Nexalin Technology has a beta of 4.6, indicating that its share price is 360% more volatile than the S&P 500. Which has preferable valuation and earnings, STRR or NXL? Star Equity has higher revenue and earnings than Nexalin Technology. Nexalin Technology is trading at a lower price-to-earnings ratio than Star Equity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStar Equity$53.36M0.13$25.13M-$3.91-0.56Nexalin Technology$168.72K141.40-$4.65M-$0.82-2.18 Does the MarketBeat Community believe in STRR or NXL? Star Equity received 1 more outperform votes than Nexalin Technology when rated by MarketBeat users. Likewise, 100.00% of users gave Star Equity an outperform vote while only 66.67% of users gave Nexalin Technology an outperform vote. CompanyUnderperformOutperformStar EquityOutperform Votes3100.00% Underperform VotesNo VotesNexalin TechnologyOutperform Votes266.67% Underperform Votes133.33% Is STRR or NXL more profitable? Star Equity has a net margin of -12.41% compared to Nexalin Technology's net margin of -3,407.98%. Star Equity's return on equity of -8.72% beat Nexalin Technology's return on equity.Company Net Margins Return on Equity Return on Assets Star Equity-12.41% -8.72% -4.62% Nexalin Technology -3,407.98%-187.59%-167.21% Do insiders & institutionals believe in STRR or NXL? 3.8% of Star Equity shares are owned by institutional investors. Comparatively, 0.6% of Nexalin Technology shares are owned by institutional investors. 33.5% of Star Equity shares are owned by company insiders. Comparatively, 24.0% of Nexalin Technology shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media favor STRR or NXL? In the previous week, Nexalin Technology had 1 more articles in the media than Star Equity. MarketBeat recorded 3 mentions for Nexalin Technology and 2 mentions for Star Equity. Star Equity's average media sentiment score of 1.43 beat Nexalin Technology's score of 0.71 indicating that Star Equity is being referred to more favorably in the media. Company Overall Sentiment Star Equity Positive Nexalin Technology Positive SummaryStar Equity beats Nexalin Technology on 11 of the 18 factors compared between the two stocks. Get Star Equity News Delivered to You Automatically Sign up to receive the latest news and ratings for STRR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STRR vs. The Competition Export to ExcelMetricStar EquityElectromedical equipment IndustryMulti-Sector SectorNASDAQ ExchangeMarket Cap$7.04M$3.18B$13.09B$7.92BDividend YieldN/A1.80%3.71%4.22%P/E Ratio-0.8515.429.7518.54Price / Sales0.1355.553.11103.35Price / Cash6.1144.0913.3534.62Price / Book0.153.531.964.25Net Income$25.13M$94.03M$959.43M$248.18M7 Day Performance9.85%3.65%0.36%1.25%1 Month Performance-7.37%7.02%-2.75%3.76%1 Year Performance-52.42%-18.01%-6.28%5.28% Star Equity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STRRStar Equity2.1206 of 5 stars$2.19+1.2%N/A-52.5%$7.04M$53.36M-0.85460Short Interest ↓Positive NewsHigh Trading VolumeNXLNexalin Technology2.5454 of 5 stars$1.73+2.7%$5.00+188.4%+19.0%$23.07M$168,721.00-2.713News CoverageNEPHNephros2.3766 of 5 stars$1.97-1.5%$5.00+153.8%-11.9%$20.88M$14.16M-21.8930Upcoming EarningsShort Interest ↓News CoverageRVPRetractable TechnologiesN/A$0.69-1.1%N/A-31.8%$20.66M$33.05M-1.28240Analyst ForecastGap UpNXGLNEXGEL1.5322 of 5 stars$2.54-10.2%N/A+23.1%$19.44M$8.69M-4.3810Short Interest ↓Positive NewsGap UpQTIQT ImagingN/A$0.70+6.4%N/A-5.1%$18.99M$4.00M0.00N/AUpcoming EarningsGap DownPTHLPheton Holdings Ltd Class A Ordinary SharesN/A$2.72-2.9%N/AN/A$17.90M$448,196.000.0011Positive NewsGap UpIRIXIRIDEX2.1323 of 5 stars$1.03+1.0%$2.00+94.2%-58.2%$17.29M$48.67M-1.54120News CoverageHigh Trading VolumeXAIRBeyond Air4.4568 of 5 stars$0.23-3.5%$3.67+1,485.9%-82.0%$15.91M$3.02M-0.2270High Trading VolumeLFWDReWalk Robotics2.5528 of 5 stars$1.43+0.7%$9.00+529.4%-70.3%$15.20M$25.66M-0.5760VVOSVivos Therapeutics2.7954 of 5 stars$2.20+4.8%$6.10+177.3%+12.3%$12.96M$15.03M-0.39160Short Interest ↓Positive NewsGap Down Related Companies and Tools Related Companies Nexalin Technology Competitors Nephros Competitors Retractable Technologies Competitors NEXGEL Competitors QT Imaging Competitors Pheton Holdings Ltd Class A Ordinary Shares Competitors IRIDEX Competitors Beyond Air Competitors ReWalk Robotics Competitors Vivos Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:STRR) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Star Equity Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Star Equity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.